Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders. The goal of the Canbex lead programme is to set a new standard in the treatment of spasticity, through improved tolerability.
Member count: 11-50
Investors 1
| Date | Name | Website |
| 07.12.2021 | M Ventures | m-ventures... |